Does TREPROSTINIL Cause Cholelithiasis? 119 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 119 reports of Cholelithiasis have been filed in association with TREPROSTINIL (TYVASO). This represents 0.1% of all adverse event reports for TREPROSTINIL.
119
Reports of Cholelithiasis with TREPROSTINIL
0.1%
of all TREPROSTINIL reports
8
Deaths
100
Hospitalizations
How Dangerous Is Cholelithiasis From TREPROSTINIL?
Of the 119 reports, 8 (6.7%) resulted in death, 100 (84.0%) required hospitalization, and 5 (4.2%) were considered life-threatening.
Is Cholelithiasis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TREPROSTINIL. However, 119 reports have been filed with the FAERS database.
What Other Side Effects Does TREPROSTINIL Cause?
Dyspnoea (16,348)
Headache (14,051)
Diarrhoea (11,335)
Nausea (10,320)
Cough (8,945)
Fatigue (7,440)
Dizziness (7,405)
Infusion site pain (5,169)
Vomiting (5,097)
Death (4,764)
What Other Drugs Cause Cholelithiasis?
ADALIMUMAB (1,238)
OCTREOTIDE (641)
SEMAGLUTIDE (571)
METHOTREXATE (466)
TIRZEPATIDE (386)
PREDNISONE (346)
ETANERCEPT (345)
ACETAMINOPHEN (313)
LENALIDOMIDE (308)
CEFTRIAXONE (306)
Which TREPROSTINIL Alternatives Have Lower Cholelithiasis Risk?
TREPROSTINIL vs TREPROSTINIL DIOLAMINE
TREPROSTINIL vs TRETINOIN
TREPROSTINIL vs TRIAMCINOLONE
TREPROSTINIL vs TRIAMCINOLONE ACETONIDE
TREPROSTINIL vs TRIAMCINOLONE HEXACETONIDE